INFECTIOUS DISEASE

Moderna's cash hits $15B, new vaccine details released

Moderna has started submitting data for the evaluation of a third booster dose at the 50 µg dose level to both the Food and Drug Administration and the European Medicines Agency. The booster dose has been found to produce "robust antibody responses" in a phase 2 study.

No shot, no proof, no service: NYC businesses begin checks

People dining indoors at New York City's restaurants, browsing art at its museums or sweating in its gyms had to show proof Tuesday that they were at least partially inoculated against COVID-19 as the city began the nation's largest effort yet to exclude the unvaccinated from public places.